Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 114
of 6Next
1:

Anti-PF4/heparin antibodies associated with repeated hemofiltration-filter clotting: a retrospective study.

Lasocki S, Piednoir P, Ajzenberg N, Geffroy A, Benbara A, Montravers P.

Crit Care. 2008;12(3):R84. Epub 2008 Jun 25.

PMID: 18578859 [PubMed - indexed for MEDLINE]

2:

IgG classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support.

Schenk S, El-Banayosy A, Morshuis M, Arusoglu L, Eichler P, Lubenow N, Tenderich G, Koerfer R, Greinacher A, Prohaska W.

J Thromb Haemost. 2007 Feb;5(2):235-41. Epub 2006 Oct 31.

PMID: 17083649 [PubMed - indexed for MEDLINE]

3:

The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.

Carrier M, Knoll GA, Kovacs MJ, Moore JC, Fergusson D, Rodger MA.

Thromb Res. 2007;120(2):215-20. Epub 2006 Nov 13.

PMID: 17098277 [PubMed - indexed for MEDLINE]

4:

Enoxaparin vs. unfractionated heparin for anticoagulation during continuous veno-venous hemofiltration: a randomized controlled crossover study.

Joannidis M, Kountchev J, Rauchenzauner M, Schusterschitz N, Ulmer H, Mayr A, Bellmann R.

Intensive Care Med. 2007 Sep;33(9):1571-9. Epub 2007 Jun 12.

PMID: 17563874 [PubMed - indexed for MEDLINE]

5:

Predictors for the development of elevated anti-heparin/platelet factor 4 antibody titers in patients undergoing cardiac catheterization.

Yeh RW, Everett BM, Foo SY, Dorer DJ, Laposata M, Van Cott EM, Jang IK.

Am J Cardiol. 2006 Aug 1;98(3):419-21. Epub 2006 Jun 12.

PMID: 16860036 [PubMed - indexed for MEDLINE]

6:

Continuous veno-venous hemofiltration without anticoagulation in high-risk patients.

Tan HK, Baldwin I, Bellomo R.

Intensive Care Med. 2000 Nov;26(11):1652-7.

PMID: 11193272 [PubMed - indexed for MEDLINE]

7:

Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia.

Alberio L, Kimmerle S, Baumann A, Taleghani BM, Biasiutti FD, Lämmle B.

Am J Med. 2003 May;114(7):528-36.

PMID: 12753876 [PubMed - indexed for MEDLINE]

8:

Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model.

Reilly MP, Taylor SM, Franklin C, Sachais BS, Cines DB, Williams KJ, McKenzie SE.

J Thromb Haemost. 2006 Dec;4(12):2687-94. Epub 2006 Sep 8.

PMID: 16961586 [PubMed - indexed for MEDLINE]

9:

A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration.

Reeves JH, Cumming AR, Gallagher L, O'Brien JL, Santamaria JD.

Crit Care Med. 1999 Oct;27(10):2224-8.

PMID: 10548211 [PubMed - indexed for MEDLINE]

10:

A fatal low-molecular-weight heparin-associated thrombocytopenia after hip surgery: possible usefulness of PF4-heparin ELISA test.

Elalamy I, Potevin F, Lecrubier C, Bara L, Marie JP, Samama MM.

Blood Coagul Fibrinolysis. 1996 Oct;7(7):665-71.

PMID: 8958387 [PubMed - indexed for MEDLINE]

11:

Prevalence of heparin/platelet factor 4 antibodies before and after cardiac surgery.

Everett BM, Yeh R, Foo SY, Criss D, Van Cott EM, Laposata M, Avery EG, Hoffman WD, Walker J, Torchiana D, Jang IK.

Ann Thorac Surg. 2007 Feb;83(2):592-7.

PMID: 17257993 [PubMed - indexed for MEDLINE]

12:

Heparin-platelet factor 4 antibodies are frequent after vascular surgery but are not a frequent cause of graft thrombosis or thrombocytopenia.

Alexy T, Tucker S, Boyle S, Rowe VL, Weaver FA, Liebman HA.

J Vasc Surg. 2008 Aug;48(2):377-81. Epub 2008 Jun 2.

PMID: 18515040 [PubMed - indexed for MEDLINE]

13:

Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen.

Greinacher A, Pötzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C.

Thromb Haemost. 1994 Feb;71(2):247-51.

PMID: 8191407 [PubMed - indexed for MEDLINE]

14:

Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia.

Amiral J, Marfaing-Koka A, Wolf M, Alessi MC, Tardy B, Boyer-Neumann C, Vissac AM, Fressinaud E, Poncz M, Meyer D.

Blood. 1996 Jul 15;88(2):410-6.

PMID: 8695787 [PubMed - indexed for MEDLINE]

15:

Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.

Amiral J, Bridey F, Wolf M, Boyer-Neumann C, Fressinaud E, Vissac AM, Peynaud-Debayle E, Dreyfus M, Meyer D.

Thromb Haemost. 1995 Jan;73(1):21-8.

PMID: 7740492 [PubMed - indexed for MEDLINE]

16:

Prevalence of heparin-induced thrombocytopenia in patients undergoing cardiac catheterization.

Foo SY, Everett BM, Yeh RW, Criss D, Laposata M, Van Cott EM, Jang IK.

Am Heart J. 2006 Aug;152(2):290.e1-7.

PMID: 16875910 [PubMed - indexed for MEDLINE]

17:

Commercial low-citrate anticoagulation haemofiltration in high risk patients with frequent filter clotting.

Naka T, Egi M, Bellomo R, Cole L, French C, Botha J, Wan L, Fealy N, Baldwin I.

Anaesth Intensive Care. 2005 Oct;33(5):601-8.

PMID: 16235478 [PubMed - indexed for MEDLINE]

18:

Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.

Untch B, Ahmad S, Jeske WP, Messmore HL, Hoppensteadt DA, Walenga JM, Lietz H, Fareed J.

Thromb Res. 2002 Jan 15;105(2):117-23.

PMID: 11958801 [PubMed - indexed for MEDLINE]

19:

Heparin-induced thrombocytopenia: a prospective study on the incidence, platelet-activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes.

Greinacher A, Juhl D, Strobel U, Wessel A, Lubenow N, Selleng K, Eichler P, Warkentin TE.

J Thromb Haemost. 2007 Aug;5(8):1666-73. Epub 2007 May 7.

PMID: 17488345 [PubMed - indexed for MEDLINE]

20:

Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia.

Fabris F, Luzzatto G, Soini B, Ramon R, Scandellari R, Randi ML, Girolami A.

J Intern Med. 2002 Aug;252(2):149-54.

PMID: 12190890 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 114
of 6Next